DBV Technologies S.A. (DBVT) Form 10-Q — Oct 28, 2026
DBV Technologies' Q3 2026 10-Q carries a going-concern warning: management concluded its $165.7 million in cash is not sufficient to fund operations for at least twelve months, with runway estimated only into Q3 2027. The nine-month net loss widened 59% to $162.5 million as R&D, sales and G&A spend scaled for the potential U.S. launch of VIASKIN Peanut. The positives are real: DBV submitted its BLA for VIASKIN Peanut in children ages 4-7 on September 29, 2026 and requested Priority Review, raised $50 million via ATM at $13.67 per ADS from RA Capital, and collected $94.7 million from PIPE warrant exercises in January.
Key figures
- Total Assets
- 215.4
- Cash Position
- 165.7
- Shares Outstanding
- 314388807
- Cash runway
- into the third quarter of 2027
- Atm price per ads usd
- 13.67
- Atm gross proceeds usd
- 50000000
- Shareholders equity musd
- 148.6
- Total equity raised since inception musd
- 1753.7
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.